A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
Clinical trial NCT06516965 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06516965
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2026-10-19
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.